Bio Usawa has a singular mission: to manufacture high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
Click here to learn more about our Company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
Former FDA Director Eric Karikari-Boateng joins Bio Usawa to lead its global regulatory strategy. Bio Usawa, Inc., a leading biotechnology company co…
January 2025Are you attending JPM Healthcare Conference in San Francisco? Several senior leadership team members of Bio Usawa, Inc (Bio Usawa), - a company deeply …
January 2025Bio Usawa, Inc (BUI Website) is pleased to announce that its Co-Founder and CEO, Menghis Bairu, MD, joined the Board of Directors of the #Society for Eq…
January 2025